Intravenous glucose administration in fasting rats has differential effects on acylated and unacylated ghrelin in the portal and systemic circulation: A comparison between portal and peripheral concentrations in anesthetized rats

Endocrinology

Volumn 148, Issue 11, 2007, Pages 5278-5287

  Gauna, Carlotta ^a   Uitterlinden, Piet ^a   Kramer, Piet ^a   Kiewiet, Rosalie M ^a   Janssen, Joop A M J L ^a   Delhanty, Patric J D ^a   Van Aken, Maarten O ^a   Ghigo, Ezio ^b   Hofland, Leo J ^a   Themmen, Axel P N ^a   Van Der Lely, Aart Jan ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TURIN   (Italy)

^c Postgraduate School of Molecular Medicine   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCOSE; INSULIN; SODIUM CHLORIDE;

ACYLATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIVER CLEARANCE; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION;

ACETYLATION; ACETYLTRANSFERASES; ANESTHESIA; ANIMALS; BLOOD CIRCULATION; FASTING; GHRELIN; GLUCOSE; GLUCOSE TOLERANCE TEST; INJECTIONS, INTRAVENOUS; INSULIN; LIVER; MALE; PORTAL VEIN; RATS; RATS, WISTAR;

EID: 35548973084     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0225     Document Type: Article

References (34)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
2. Kojima M, Hosoda H, Kangawa K 2001 Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Horm Res 56:93-97
3. Dezaki K, Sone H, Koizumi M, Nakata M, Kakei M, Nagai H, Hosoda H, Kangawa K, Yada T 2006 Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55:3486-3493
4. Davenport AP, Bonner TI, Foord SM, Harmar AJ, Neubig RR, Pin JP, Spedding M, Kojima M, Kangawa K 2005 International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev 57:541-546
5. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709
6. Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
7. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M 2001 Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145:669-673
8. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719
9. McCowen KC, Maykel JA, Bistrian BR, Ling PR 2002 Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J Endocrinol 175:R7-R11
10. Nakagawa E, Nagaya N, Okumura H, Enomoto M, Oya H, Ono F, Hosoda H, Kojima M, Kangawa K 2002 Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond) 103:325-328
11. Broglio F, Gottero C, Prodam F, Destefanis S, Gauna C, Me E, Riganti F, Vivenza D, Rapa A, Martina V, Arvat E, Bona G, van der Lely AJ, Ghigo E 2004 Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans. Clin Endocrinol (Oxf) 61:503-509
12. Faber OK, Madsbad S, Kehlet H, Binder C 1979 Pancreatic β cell secretion during oral and intravenous glucose administration. Acta Med Scand Suppl 624:61-64
13. Hampton SM, Morgan LM, Tredger JA, Cramb R, Marks V 1986 Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion. Diabetes 35:612-616
14. Meier JJ, Veldhuis JD, Butler PC 2005 Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes 54:1649-1656
15. Toffolo G, Campioni M, Basu R, Rizza RA, Cobelli C 2006 A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am J Physiol Endocrinol Metab 290:E169-E176
16. Mundinger TO, Cummings DE, Taborsky Jr GJ 2006 Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 147:2893-2901
17. Ross H, Johnston ID, Welborn TA, Wright AD 1966 Effect of abdominal operation on glucose tolerance and serum levels of insulin, growth hormone, and hydrocortisone. Lancet 2:563-566
18. Aynsley-Green A, Biebuyck JF, Alberti KG 1973 Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia 9:274-281
19. Johansen O, Vaaler S, Jorde R, Reikeras O 1994 Increased plasma glucose levels after Hypnorm anaesthesia, but not after pentobarbital anaesthesia in rats. Lab Anim 28:244-248
20. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F, Kangawa K 2004 Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem 50:1077-1080
21. Groschl M, Uhr M, Kraus T 2004 Evaluation of the comparability of commercial ghrelin assays. Clin Chem 50:457-458
22. Kaden M, Harding P, Field JB 1973 Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog. J Clin Invest 52:2016-2028
23. Balks HJ, Jungermann K 1984 Regulation of peripheral insulin/glucagon levels by rat liver. Eur J Biochem 141:645-650
24. Gordon ME, McKeever KH 2006 Oral and intravenous carbohydrate challenges decrease active ghrelin concentrations and alter hormones related to control of energy metabolism in horses. J Anim Sci 84:1682-1690
25. Hotta M, Ohwada R, Katakami H, Shibasaki T, Hizuka N, Takano K 2004 Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab 89:5707-5712
26. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, Sherwin RS 2003 The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284:E313-E316
27. Saad MF, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R 2002 Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87:3997-4000
28. Briatore L, Andraghetti G, Cordera R 2003 Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. Eur J Endocrinol 149:403-406
29. Van Der Lely AJ, Tschop M, Heiman ML, Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457
30. Duckworth WC, Bennett RG, Hamel FG 1998 Insulin degradation: progress and potential. Endocr Rev 19:608-624
31. Song SH, McIntyre SS, Shah H, Veldhuis JD, Hayes PC, Butler PC 2000 Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab 85:4491-4499
32. De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P, Delporte C 2004 Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 145:4997-5005
33. Gauna C, Delhanty PJ, van Aken MO, Janssen JA, Themmen AP, Hofland LJ, Culler M, Broglio F, Ghigo E, van der Lely AJ 2006 Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol Cell Endocrinol 251:103-111
34. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K, Chihara K 2002 Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 277:5667-5674